Efficacy of metformin treatment in polycystic ovary syndrome

Učinkovitost zdravljenja sindroma policističnih jajčnikov z metforminom

  • Katja Jerenec University of Maribor, Faculty of Medicine
  • Maša Samojlenko University of Maribor, Faculty of Medicine
  • Ksenija Geršak University of Ljubljana, Faculty of Medicine, Department of Obstetrics and Gynaecology ; University Medical Centre Ljubljana
  • Polonca Ferk University of Maribor, Faculty of Medicine
Keywords: polycystic ovary syndrome, metformin, pharmacogenetics, personalized medicine

Abstract

Metformin is an oral antidiabetic drug with potentially beneficial effects in patients with polycystic ovary syndrome (PCOS). Different pharmacological responses to met- formin have been reported in PCOS patients, which may be attributable to various clinical, biochemical, genetic and other factors. Here, we have outlined a short review of the results from current clinical studies on metformin efficacy in PCOS patients. Additionally, preliminary results from a retrospective pharmacogenetic study by our group on a sample of Slovene PCOS patients are presented. Pharmacogenetics is an emerging science that should pro- vide options for individualized medicine, the future of healthcare.

Downloads

Download data is not yet available.

Author Biographies

Katja Jerenec, University of Maribor, Faculty of Medicine

Maribor, Slovenia.

Maša Samojlenko, University of Maribor, Faculty of Medicine

Maribor, Slovenia.

Ksenija Geršak, University of Ljubljana, Faculty of Medicine, Department of Obstetrics and Gynaecology ; University Medical Centre Ljubljana

Ljubljana, Slovenia.

Polonca Ferk, University of Maribor, Faculty of Medicine

Assist. Prof., Maribor, Slovenia. E–mail: polonca.ferk@guest.arnes.si

Published
2021-11-27
How to Cite
Jerenec K., Samojlenko M., Geršak K., & Ferk P. (2021). Efficacy of metformin treatment in polycystic ovary syndrome. Acta Medico-Biotechnica, 6(2), 13-20. https://doi.org/10.18690/actabiomed.87
Section
Articles